Evidence map›Paper›PMID 41585199›Full record

ArticleJournal of dental sciences2026

Development of bio-compatible isosorbide-based polyurethanes exhibiting eucalyptol solubility for advanced root canal filling applications.

Yuen-Shan Tsai, Sheng-Wun Huang, Yin-Lin Wang, Shu-Fang Chang, Chun-Pin Lin

Abstract read
In one paragraph

Article in Journal of dental sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuen-Shan TsaiGraduate Institute of Oral Biology, School of Dentistry, National Taiwan University, Taipei, Taiwan.
Sheng-Wun HuangGraduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan.
Yin-Lin WangGraduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan.
Shu-Fang ChangDepartment of Dentistry, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
Chun-Pin LinGraduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/purpose: Gutta-percha (GP) has long been the standard root canal filling material, but its poor removability, limited mechanical properties, and potential cytotoxicity restrict clinical performance. To address these shortcomings, this study aimed to develop bio-based D-isosorbide thermoplastic polyurethanes (IPUs) with improved removability in eucalyptol oil, superior mechanical performance, and enhanced cytocompatibility, providing a potential alternative to GP. Materials and methods: D-isosorbide-based IPUs were synthesized from polycarbonate polyol and D-isosorbide via catalyst-free, two-step polymerization. Four formulations with different hard segment contents (HS10-HS40) were prepared and evaluated for thermal stability (thermogravimetric analysis and differential scanning calorimetry), mechanical properties (tensile testing), solubility in eucalyptol oil, and cytocompatibility (CCK-8 and LDH assays), compared with GP. Results: All IPUs showed high thermal stability (T Conclusion: D-isosorbide-based IPUs combine favorable thermal and mechanical properties with partial solubility in eucalyptol, enabling easier and safer retreatment. Their excellent cytocompatibility further supports their potential as sustainable and clinically viable alternatives to GP in root canal obturation.

Indexed as

BiocompatibilityEucalyptolIsosorbideRetreatmentRoot canal filling materialsThermoplastic polyurethane

Identifiers

PMID41585199
PMCPMC12827010

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.